Related Experiment Video
Updated: Feb 7, 2026

Direct Measurement of KDM1A Target Engagement Using Chemoprobe-based Immunoassays
Published on: June 13, 2019
Homogeneous BTK Occupancy Assay for Pharmacodynamic Assessment of Tirabrutinib (GS-4059/ONO-4059) Target Engagement
Helen Yu1, Hoa Truong1, Scott A Mitchell1
11 Gilead Sciences, Inc., Foster City, CA, USA.
Abstract:
Bruton's tyrosine kinase (BTK) is a clinically validated target for B-cell leukemias and lymphomas with FDA-approved small-molecule inhibitors ibrutinib and acalabrutinib. Tirabrutinib (GS-4059/ONO-4059, Gilead Sciences, Inc., Foster City, CA) is a second-generation, potent, selective, irreversible BTK inhibitor in clinical development for lymphoid malignancies, including chronic lymphocytic leukemia (CLL) and diffuse large B-cell lymphoma (DLBCL). An accurate pharmacodynamic assay to assess tirabrutinib target coverage in phase 1/2 clinical studies will inform dose and schedule selection for advanced clinical evaluation. We developed a novel duplex homogeneous BTK occupancy assay based on time-resolved fluorescence resonance energy transfer (TR-FRET) to measure free and total BTK levels in a multiplexed format. The dual-wavelength emission property of terbium-conjugated anti-BTK antibody served as the energy donor for two fluorescent energy acceptors with distinct excitation and emission spectra. The assay was characterized and qualified using full-length purified recombinant human BTK protein and peripheral blood mononuclear cells derived from healthy volunteers and patients with CLL. We demonstrated assay utility using cells derived from lymph node and bone marrow samples from patients with CLL and DLBCL. Our TR-FRET-based BTK occupancy assay provides accurate, quantitative assessment of BTK occupancy in the clinical trial program for tirabrutinib and is in use in ongoing clinical studies.
Insights
A new assay accurately measures Bruton
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Bruton's tyrosine kinase (BTK) is a validated therapeutic target for B-cell malignancies.
- Approved BTK inhibitors include ibrutinib and acalabrutinib.
- Tirabrutinib is a second-generation BTK inhibitor in clinical development for lymphoid malignancies.
Purpose of the Study:
- To develop and qualify a pharmacodynamic assay for tirabrutinib.
- To assess tirabrutinib target coverage in clinical studies.
- To inform dose and schedule selection for tirabrutinib.
Main Methods:
- Developed a novel duplex homogeneous assay using time-resolved fluorescence resonance energy transfer (TR-FRET).
- Measured free and total Bruton's tyrosine kinase (BTK) levels in a multiplexed format.
- Utilized terbium-conjugated anti-BTK antibody as energy donor and distinct fluorescent acceptors.
Main Results:
- The TR-FRET assay was characterized and qualified using recombinant BTK protein and peripheral blood mononuclear cells.
- Assay utility was demonstrated in cells from lymph node and bone marrow samples of patients with CLL and DLBCL.
- The assay accurately quantifies BTK occupancy.
Conclusions:
- A novel TR-FRET-based BTK occupancy assay was developed and qualified.
- This assay provides accurate, quantitative assessment of BTK occupancy.
- The assay is utilized in ongoing clinical studies for tirabrutinib.
Related Concept Videos
Test for Homogeneity
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamics in Geriatric Patients: Effects of Age
Homogeneous Equilibria for Gaseous Reactions
For gas-phase reactions, the equilibrium constant may be expressed in terms of either the molar concentrations (Kc) or partial pressures (Kp) of the reactants and products. A relation between these two K values may be simply derived from the ideal gas equation and the definition of molarity. According to the ideal gas equation:
Tissue Homogenization and Cell Lysis
Mechanical methods of tissue homogenization
These methods rely on applying external physical force to disrupt...

